Vedolizumab Biosimilar - Research Grade
Bulk Vedolizumab Biosimilar - Research Grade
Product Specific Citations:
Dipasquale et al. Biosimilars in Pediatric IBD: Updated Considerations for Disease Management. Biologics (2022).
Parrish II et al. Biosimilar Interchangeability and Emerging Treatment Strategies for Inflammatory Bowel Diseases: A Commentary. Gastroenterology Insights (2021).
Product Benefits:
ichorbio's Vedolizumab Biosimilar - Research Grade is manufactured in a cGMP compliant facility. ichorbio: the best antibodies for in vivo research.
Size:
ichorbio's research grade vedolizumab biosimilar is available in the following sizes: 5mg, 10mg, 20mg, 50mg, 100mg ichorbio regularly manufactures bulk multi-gram amounts of our vedolizumab biosimilar - please contact us for pricing.
Target:
Integrin a4b7
Clone:
n/a
Isotype:
IgG1
Other Names:
Integrin Beta 7, Integrin Alpha 4, ITGA4, ITGB7, CD49
Host:
Humanized
Species Reactivity:
Human
Specificity:
Detects human Integrin α4β7.
Purification Method:
This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.
Background:
Vedolizumab, an integrin receptor antagonist, is a humanized IgG1 monoclonal antibody produced in Chinese hamster ovary cells that binds to the human α4β7 integrin. Vedolizumab has an approximate molecular weight of 147 kilodaltons.
Concentration:
1.0 - 5.0 mg/ml
Formulation:
Sterile, preservative-free, clear to pale yellow solution, pH 6.3, containing L-histamine Acid, L-histidine monohydrate hydrochloride, L-arginine hydrochloride, sucrose, and polysorbate 80. BSA and Azide free.
Purity:
>95% by SDS-PAGE and HPLC
Endotoxin:
≤ 0.75 EU/mg as determined by the LAL method
Storage:
Vedolizumab Biosimilar - Research Grade is stable for at least four (4) weeks when stored sterile at 2-8°C. For long term storage aseptically aliquot in working volumes without diluting and store at –80°C. Avoid Repeated Freeze Thaw Cycles.
Applications:
Functional Assays
Application Notes:
Each investigator should determine their own optimal working dilution for specific applications.
Use: ichorbio's vedolizumab biosimilar is for research use only (RUO).
Isotype Control:
Concentration | 13mg/ml |
---|---|
isotype | IgG1 |
Host | Humanized |